Prescription drug spending continues to be one of the most significant cost pressures facing employee benefit plans. While new therapies are improving outcomes for many patients, they are also driving higher utilization and increasing financial strain for plan sponsors. Addressing this challenge requires more than reactive measures. It calls for a more strategic approach to how pharmacy benefits are managed and administered.
One of the most important tools in this effort is Pharmacy Benefit Administration (PBA). PBA services help plan sponsors gain greater visibility into prescription drug use, apply clinical oversight, and improve how pharmacy benefits are delivered. As drug utilization increases and treatment options expand, effective pharmacy benefit administration has become a critical component of overall plan performance.
Recent data from the Centers for Medicare & Medicaid Services shows that U.S. prescription drug spending reached approximately $467 billion in 2024, reflecting continued growth driven largely by increased utilization rather than pricing alone. This trend highlights an important shift. The challenge is no longer only about managing price increases, but also about understanding how medications are used across a population and ensuring they are used appropriately.
For plan sponsors, this creates a need for greater control and insight. Pharmacy benefits are closely tied to overall healthcare spending, making them a key factor in both financial performance and participant outcomes. A well-managed pharmacy benefit strategy allows organizations to respond proactively rather than react after costs have already escalated.
Data plays a central role in this process. Access to real time reporting and analytics helps identify prescribing patterns, utilization trends, and cost drivers. With this visibility, plan sponsors can identify inefficiencies and make more informed decisions that support long term sustainability.
Clinical oversight is equally important. Applying evidence-based guidelines ensures that medications are appropriate, necessary, and aligned with treatment standards. This is especially critical for specialty drugs, which continue to account for a growing portion of overall pharmacy spending and require careful management to balance cost and access.
The participant experience also has a meaningful impact. When employees understand their benefits and have access to clear, convenient tools, they are more likely to seek care in a timely manner and follow prescribed treatments. This leads to better outcomes and helps reduce avoidable costs.
Taken together, these factors reflect a broader shift in how pharmacy benefits are managed. Plans that integrate data, clinical oversight, and participant engagement are better positioned to manage complexity and deliver sustainable value.
How Amalgamated Supports Pharmacy Benefit Administration
Amalgamated Employee Benefits Administrators (Amalgamated) supports plan sponsors through its AEBRx Pharmacy Benefit Administration service, which is designed to improve visibility, strengthen clinical oversight, and help manage high cost and specialty drug utilization. With real time reporting, prior authorization review processes, and access to a large national pharmacy network, AEBRx helps plans operate more efficiently while supporting appropriate care.
Amalgamated’s work is grounded in a long union heritage and a commitment to serving working people. That perspective continues to shape a focus on transparency, fairness, and responsible benefit administration.
To learn more about how AEBRx can support your organization’s pharmacy benefit strategy and help manage rising drug costs, contact us today.
